retatrutide triple hormone receptor agonist metabolic for dysfunction-associated steatotic liver disease: a randomized phase 2a trial Retatrutide Explained: The Triple Agonist

Our team takes the time to understand your unique skin concerns, your aesthetic goals, and your overall health history including any recent weight changes before recommending a personalized treatment plan

Check for Skin Reactions If you notice redness, itching, or irritation, stop using them immediately

For example, some compounded versions of GLP-1s include the investigational drug retatrutide, which is illegal for compounding and hasnt been FDA-approved

It's now active, alive, and incredibly vulnerable

Compounded Medication Notice

Why These Three Work Together Retatrutide, Tesamorelin, and MOTS-C target different pathways that compound on each other: Retatrutide is a triple-agonist GLP-1/GIP/glucagon receptor agonist